Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Associate

Biomedical Science · Bangladesh · 2025-04-01

Processing Time
309 days
Decision Date
2025-04-01
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical challenges in cancer therapy and vaccine manufacturing, supporting U.S. public health and pandemic preparedness.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a record of 12 publications and 172 citations, showing a track record of scientific contributions.

3 Balance of Interests Met

USCIS found the urgency and value of the petitioner's contributions to biomedical innovation justified a waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on 12 peer-reviewed journal articles (including 5 first-authored papers) and 172 citations, with several papers ranked in the top 10-20% of their field. The petitioner's work was previously supported by the Malaysian Fundamental Research Grant Scheme, demonstrating prior success and positioning. The case satisfied all three Dhanasar prongs by highlighting the national importance of cancer nanotechnology and the petitioner's Ph.D.-level expertise.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Government Alignment
Original Contributions

Similar Cases

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Arkansas 14 days 2025-02-20
The petitioner proposes to synthesize novel engineered nanoplatforms for therapeutic applications and develop non-cell culture-based efficacy determination methods for targeting therapeutic nanomaterials. The work aims to create cancer treatments with high specificity to improve treatment effectiveness while reducing off-target effects.
View Case

Consultant

Biotechnology · Turkey

WeGreened EB-2 (NIW) approved
2 days 2023-08-24
The petitioner proposes to continue research on developing cutting-edge nanotherapeutic and nanotheranostic systems, as well as toxicology assays. This work focuses on improving cancer diagnosis and treatment while evaluating and reducing the toxicity of biomedical materials and devices.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
North Carolina 132 days 2024-05-17
The petitioner proposes to continue her research in pharmaceutical sciences, specifically focusing on advancing drug repurposing and the development of nanoparticle-based delivery systems. Her work aims to create smarter, more efficient ways to deliver medications for critical diseases such as cancer and COVID-19. This research is intended to provide faster, cost-effective pathways for translating laboratory discoveries into viable clinical treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Bangladesh

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 309 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Bangladesh All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist